NCT00085566View on ClinicalTrials.gov

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Brain and Central Nervous System TumorsProstate Cancer
Interventions
DRUG

everolimus

DRUG

gefitinib

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

08035

Vall d'Hebron University Hospital, Barcelona

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00085566 - Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter